Event Details
Dates: October 16–17, 2026
Location: Hynes Convention Center, Boston, Massachusetts, and online
Event Website: https://www.asco.org/quality
Event Overview
Cizzle Bio will attend the 2026 ASCO Quality Care Symposium, taking place October 16–17 at the Hynes Convention Center in Boston and online. The symposium brings together researchers, clinicians, health-system leaders, and oncology professionals focused on improving the quality, safety, efficiency, and patient experience of cancer care.
Hosted by the American Society of Clinical Oncology (ASCO), the meeting serves as a leading forum for research and practical strategies that strengthen cancer-care delivery. More than 700 abstract titles span innovations in quality cancer care, implementation science, health services, technology, patient outcomes, and healthcare value.
The hybrid format gives attendees opportunities to engage with new research, learn from care-delivery experts, and explore scalable approaches that help ensure patients receive respectful, efficient, evidence-based, and person-centered care.
Symposium Focus
Programming at the ASCO Quality Care Symposium examines how cancer care can be improved across the full patient journey. Key areas include:
Quality and safety in oncology care delivery.
Implementation science and strategies for translating evidence into clinical practice.
Health services research, healthcare value, and system-level improvement.
Approaches to improving patient experience, communication, access, and equity.
Technology-enabled solutions and innovations that support efficient, coordinated care.
Research focused on preserving quality of life for people living with cancer.
Why Attend
Review emerging research on improving the quality, safety, and efficiency of cancer care.
Learn practical strategies that can strengthen clinical workflows and patient outcomes.
Connect with oncology clinicians, researchers, care-delivery leaders, and health-system decision-makers.
Explore scalable solutions for improving access, communication, coordination, and the patient experience.
Participate in conversations about the future of high-quality, evidence-based cancer care.
Cizzle Bio’s Focus
As a company advancing biomarker blood tests for early cancer detection, Cizzle Bio recognizes that diagnostic innovation must be supported by effective clinical workflows, clear communication, equitable access, and coordinated follow-up care.
Attending the ASCO Quality Care Symposium supports our commitment to understanding how new technologies can be integrated responsibly into cancer-care delivery. We look forward to engaging with leaders working to improve early detection, patient access, care coordination, healthcare quality, and outcomes across the oncology continuum.